Monitoring estrogen replacement therapy and identifying rapid bone losers with an immunoassay for deoxypyridinoline
Authors:
- 1 March 1998
- journal article
- clinical trial
- Published by Springer Nature in Osteoporosis International
- Vol. 8 (2) , 159-164
Abstract
We have assessed urinary deoxypyridinoline (Dpd) levels by immunoassay in women who participated in a double-masked, placebo-controlled trial of the bone loss prevention effects of estrogen replacement therapy (ERT). Ninety-one women who had undergone recent surgical menopause were randomdized to receive either placebo or 0.025, 0.05 or 0.1 mg/day transdermal 17β-estradiol for 2 years. Mean Dpd levels in the postmenopausal women were significantly elevated (pp<0.01) from baseline at 6 months following initiation of treatment with 0.05 or 0.1 mg/day 17β-estradiol, changes that correlated with increased lumbar spine BMD and with changes in mid-radius BMC. At 12 months, Dpd levels were lower than baseline and placebo in all three treatment groups. These data suggest utility of this Dpd immunoassay in assessing changes in bone resorption induced by surgical menopause and ERT.Keywords
This publication has 35 references indexed in Scilit:
- Relationship of Bone Turnover to Bone Density and FracturesJournal of Bone and Mineral Research, 1997
- The Predictive Value of Biochemical Markers of Bone Turnover for Bone Mineral Density in Early Postmenopausal Women Treated with Hormone Replacement or Calcium SupplementationThe Journal of Clinical Endocrinology & Metabolism, 1997
- The Usefulness of Bone Turnover in Predicting the Response to Transdermal Estrogen Therapy in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 1997
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- Biochemical Markers of Bone Resorption Compared with Estimates of Bone Resorption from Radiotracer Kinetic Studies in OsteoporosisJournal of Bone and Mineral Research, 1997
- ASBMR 18th Annual MeetingJournal of Bone and Mineral Research, 1996
- Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacyBone, 1996
- Automatic-interactive measurement of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinolineBone, 1995
- Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosisJournal of Bone and Mineral Research, 1993
- Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross‐links: a longitudinal and cross‐sectional studyClinical Endocrinology, 1992